STERIS Completes Expansion of Venlo The Netherlands Xray Facility

October 8, 2026

  • Supports medical device manufacturing with additional radiation processing capacity
  • Complements existing EO, gamma, X-ray, and testing services offered in The Netherlands

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completion of the expansion of its existing Venlo, The Netherlands ethylene oxide and X-ray processing facility to include a second X-ray processing line.

The expansion of the Venlo facility furthers our commitment of ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and well into the future. 

In addition to the Venlo X-ray location, we support medical device manufacturing in The Netherlands through ethylene oxide sterilization in Venlo, gamma processing in Etten-Leur, and gamma processing and laboratory testing services in Ede.

Increased demand in medical device manufacturing has accelerated our plans for global expansion. The addition of accelerator-based radiation processing options throughout our global network allows us to support Customers with both routine services and processing redundancy.

Learn more about X-ray irradiation processing here. 

Take a virtual tour of our X-ray facility in Venlo, The Netherlands here. 

STERIS Venlo, NL Facility

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 

WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe.

For more information, visit www.steris.com.

 
Related Posts
STERIS Swindon Lab, UK
November 1, 2026

As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce the launch of MALDI-ToF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) identification testing in the United Kingdom.

STERIS AST Research Highlights Considerations for ISO 11137 Dose Validation
October 29, 2026

STERIS Applied Sterilization Technologies (AST) is pleased to announce newly published research examining the effectiveness of industrial gamma and electron beam (E-beam) irradiation in inactivating Bacillus pumilus spores under varying levels of water availability.

STERIS Alajuela, Costa Rica
September 29, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the expansion of the laboratory testing capabilities available at our facility in Alajuela, Costa Rica.